65,437 trials
Pigmentation · Wrinkle
Primary: Correct Identification of Baseline Photographs vs. Photographs Taken 3 Months Post Last Treatment — 80 % of photos correctly identified
Pertussis · Whooping Cough
Primary: Number of Participants With Nasal Mucosal Seroconversion (Immunoglobulin A [IgA]) — 79; 89; 38; 42 Participants
Autism Spectrum Disorder
Primary: Vineland Adaptive Behavior Scales, 3rd Edition — 199.0; 177.9; 228.8; 203.3 Score on a scale
Glabellar Lines
Primary: The Percentage of Participants With a ≥ 2-grade Improvement From Baseline on the Facial Wrinkle Scale With Photonumeric Guide (FWS) According to INVESTIGATOR AND…
Osteoarthritis, Knee · Microfragmented Adipose Tissue · Platelet-Rich Plasma
Primary: KOOS Pain [Knee Injury and Osteoarthritis Outcome Score] — 79.95; 77.78 units on a scale — p=0.69
Extensive Stage Lung Small Cell Carcinoma · Malignant Solid Neoplasm · Metastatic Malignant Neoplasm in the Brain
Primary: Number of Participants With Dose Limiting Toxicities — 1; 2 Participants
Sickle Cell Disease
Primary: Mean Change in the Plasma Soluble P-selectin Level — 0.74; 0.10 ng/ml — p=0.64
Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)
Primary: Percentage of Participants With None or Mild in GL Severity at Maximum Frown — 46 Participants
Childhood Mortality
Primary: 6 Month Mortality - All Cause — 42; 50 Participants
Osteopenia
Primary: Change in Bone Strength Index of the Distal Tibia Based on Randomization to Control, Risedronate, or Exercise Group. — 2098.7; 1993.3; 2001; 2105.89 mg^2/mm^4 — p=0.7
Surgical Skin Preparation · Surgical Procedure, Unspecified
Primary: Comparison of Log Change of Skin Flora Relative to Pre-treatment (Baseline) in Each of 3 Sampling Sites at a Defined Post-treatment Sampling Time. — -2.19; -1.85; -2.42…
Ocular Inflammation and Pain After Cataract Surgery
Primary: Number of Treatment Emergent Adverse Events — 4; 7; 3; 8 Participants
Sedentary Lifestyle · Dementia, Mild · Mild Cognitive Impairment
Primary: Daily Steps Change From Baseline to Month 2 — 604.1 steps per day — p=0.376
Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis · Interstitial Pneumonitis
Primary: Change in 6-minute Walk Test Distance (6MWD) — 46.5; 23.2 Meters
Lateral Canthal Lines
Primary: Percentage of Participants With None or Mild in LCL Severity at Maximum Smile — 9; 10; 8; 14 Participants